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Abstract
Millions of craniofacial surgeries are performed annually worldwide for craniofacial bones’ replacement and augmentation. This
represents a significant economic burden as well as aesthetic expectations. Autografts and allografts are the first choice for
treatment of craniofacial defects; however, their limited availability and difficulty to shape have led to investigation for alternative
strategies. Biomaterial-based approaches have been used for implantation as they have ample supply but their processing through
conventional technologies present several drawbacks; the major one relates to the poor versatility towards the production of
patient-specific implants. Additive manufacturing has gained considerable attention during the last decade, as it allows the
manufacturing of implants according to patient need. Biomaterial implants can be additively manufactured but have one or more
limitations of stress shielding, radiopacity, high strength to weight ratio and limited bone integration. Over the last few decades,
composites are investigated to surmount the limitations with traditional implants and also improve their bone integration. This
review provides an overview of the most recent polymeric composite-based biomaterials that have been used in combination with
3D printing technology for the development of patient-specific craniofacial implants. Starting with the conventional treatments,
biomaterials available for the craniofacial implants, the additive manufacturing rationale are discussed. Also, the main challenges
still associated with 3D printing of polymer-based composites are critically reviewed and the future perspective presented.
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1 Introduction
Every year, approximately 69 million individuals worldwide
suffer from traumatic head injuries, which represent an enor-
mous economic burden on medical services [1], and the fore-
most cause of death and disability [2]. In 2016, ~ 74,000 cases
for traumatic head injury were reported in England [3]; these
include craniofacial fractures, which may arise when human
head and/or face are subjected to impact loading caused by
road traffic accidents, sport injuries and antisocial behaviour
[4–8]. The fractures caused by trauma are asymmetrical in
shape as compared to congenital defects which are symmetri-
cal [9]. However, the repair in both cases is challenging.
Replacement or augmentation of the physical bone is the pri-
mary aim of craniofacial surgeries, although qualitative im-
pacts on function of the bone such as issues of swallowing,
orbital function, vision, eating, speech and restoration of facial
contour symmetry also need to be addressed [2, 9, 10].
Craniofacial surgeries were performed by many ancient
civilisations such as Incas, Asians, North Africans, British
and Polynesian populations with evidences dating back 7000
BC [11]. However, the first craniofacial surgery in medical
literature, based on the use of an implant, was reported by
Fallopius and Petronius in the sixteenth century, when gold
plates were used to repair cranium defects [12]. This practice
did not continue further because the idea of using prosthetics
was not well accepted at that time and surgeons preferred to
use the patient’s own bone tissue. In eighteenth and nineteenth
centuries, autografts represented the common practice. In this
case, the tissue was explanted from a healthy site and used to
treat the injured site. This would not cause any immunogenic
complication; however, the extraction of tissue itself was the
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cause of a second injured site. The limited availability of au-
tograft along with the poor specificity in both shape and size
are the main drawbacks of this approach. The use of autografts
was discontinued and substituted by the introduction of allo-
grafts and xenografts, including tissues harvested from cadav-
eric skulls, bovine, rabbit and canine bones. However, with
time also these strategies were precluded, mainly due to their
high immune response they caused [12, 13].
During the last century, non-biological prostheses became
common for bone tissue repair. InWorldWar I, metals such as
silver and gold were considered the best candidates for cra-
niofacial surgery, while in World War II, titanium (Ti) was
frequently used [13, 14]. Although metals have been used
successfully for many years since, metallic implants do not
meet all biomechanical requirements. Particularly, stress
shielding around the implant is a frequent issue. This may
occur at the interface between metal and bone due to inade-
quate load transfer and result in the surrounding bone loss
[15]. Moreover, metallic based implants may corrode and also
cause cytotoxic reactions by releasing metallic ions into the
host body. Furthermore, their interference with radiation de-
riving from imaging techniques affects post-operative follow-
up by preventing the monitoring of the healing process
[16–18] To overcome these limitations, bioceramics such as
hydroxyapatite (HA) and tri-calcium phosphate (TCP) have
been investigated for craniofacial bone repair thanks to their
excellent bioactivity and their chemical properties similar to
that of natural human bone [19]. However, the lowmechanical
strength and the brittle nature of bulk ceramics circumscribe
their application in bone repair [20]. In order to overcome the
limitations of bioceramics, researchers have combined them
with other materials. Bioceramics have successfully been used
as a coating for metallic implants and to reinforce polymeric
matrices [21–23]. Considerable research is on-going to devel-
op materials that have suitable biomechanical characteristics
for implantation. Specifically, polyetherether ketone (PEEK),
polyetherketone ketone (PEKK), polymethylmethacrylate
(PMMA), polyethylene (PE) and their composites [22,
24–26]. In addition to being biocompatible and mechanically
strong, they have the advantage over metallic implants of be-
ing radiolucent. Hence, the radiographic imaging assessment
of their fusion with native bone (i.e. magnetic resonance im-
aging (MRI), computed tomography (CT) and X-ray scans) is
facilitated as opposed to the interference caused by metallic
implants [26–28].
Matching the host geometry is important to achieve aesthet-
ic pleasing results and also complimenting the biological func-
tion [29]. Traditional manufacturing techniques such as injec-
tion moulding [30], casting [31] and extrusion [32] have been
used for manufacturing craniofacial implants; however, they
are time-consuming and not cost-effective for the production
of patient-specific implants, and also the accuracy and preci-
sion of injection moulded samples is subjected to shrinkage
control [33, 34]. In the last decade, greater attention has been
given to the use of additive manufacturing (AM), and the op-
portunity this type of technologies offers towards the produc-
tion of personalised implants [35]. AM, also referred as 3D
printing, is a manufacturing technique capable of producing
complex 3D geometrical structures in a layer-by-layer fashion,
starting from a digital CAD (computer-aided designing) model
[36]. Materials ranging from metal, ceramics, polymers and
their composites can be processed by additive manufacturing
technologies [37]. Nowadays, the use of biocompatible poly-
mers such as PEEK, PEKK and PMMA in combination with
additive manufacturing is gaining great interest for the devel-
opment of custom-made and patient specific craniofacial im-
plants [38, 39], although the processing of polymer-based com-
posites through 3D printing has been only marginally investi-
gated for this specific clinical application [40].
In this review, the evolution of craniofacial implants will be
discussed along with an overview of the most recent polymer-
ic composite-based biomaterials that have been used in com-
bination with 3D printing technology for the development of
patient-specific craniofacial implants. The main challenges
associated with 3D printing of biocompatible polymer-based
composites will be critically reviewed. Finally, a roadmap for
the future development of such implants will be laid out.
2 Anatomical and biomechanical
considerations for craniofacial implant
development
Craniofacial bones each have a unique physiology and func-
tion. This function needs to be considered when manufacturing
implants as the functionality of these bones is so integral to our
being [38]. Misshapen implants can give rise to social
stigmatisation, poor body image and low self-esteem.
Improper fitting of the implant can induce chronic pain and
other debilitating conditions and seriously impair the quality
of life of the patient. It is therefore imperative that the implant
fits perfectly the host tissue defect, thus has a patient-specific
design and an adequate inner geometry (i.e. porosity and inter-
connectivity), and is made of biomaterials that reflect the com-
position of human tissues, both in terms of biological and me-
chanical properties [38, 41, 42]. Adult human skull is made up
of 22 complex bones, categorised into cranial and facial bones.
Human skull provides a cavity to support the brain alongside
providing structural support to the facial bones [43]. All bones,
steadily joined together, provide a packed structure with little
movement, except for the temporomandibular joint. Human
brain case, known as the cranium, is formed of eight bones:
two parietal bones, two temporal bones, one ethmoid bone, one
frontal bone, one occipital bone and one sphenoid bone. The
other fourteen facial bones support the eyes and the entrances to
the digestive and respiratory tracts [43, 44].
Int J Adv Manuf Technol
At the macroscopic level, human bone is based on two
different categories, which differ in composition, apparent
density as well as porosity, and they are known as cortical
(or compact) and cancellous (or trabecular) bone. These dif-
ferences lead to variations in bones’ mechanical properties
depending on the different anatomical location [45]. In addi-
tion to this, mechanical properties of human bones have been
found to be dependent on gender, age group as well-diseased
states. For such reasons, they are generally ascribed in a range
of values, rather than a unique number. In Table 1, we list the
mechanical properties of human cortical bone. The bone is
usually subjected to compressive and tension forces during
normal loading in both transverse and longitudinal directions;
hence, the strength of the bone is variable in these directions
[46]. Tensile strength is a measure of its ability to withstand
tensile/pulling forces/loads, whereas compressive strength
gives a measure of the compressive loads without failure/
fracture of the bone. Young’s modulus is a mechanical prop-
erty that defines stiffness of bone, i.e. deformation in bone
shape when load is applied in a uniaxial direction [47]. The
varying properties allow user to understand the prerequisite of
implant material for the replacement of cranial bone.
Cranial bones are no exception and exhibit different prop-
erties as revealed by the wider literature. For instance, frontal
bone is thicker, is less porous and has higher percent volume
than temporal bone, which in turn increases its fracture tough-
ness [48]. Motherway et al. measured the bending strength of
right parietal, left parietal and frontal bones of the cranium,
and they found values equal to 82.98 MPa, 78.15 MPa and
102.60 MPa respectively [48], thus indicating the slight vari-
ations in mechanical properties between left vs right parietal
bones and significant difference between the bending strength
of parietal and frontal bone, which is a direct consequence of
the differences in porosity and structure of these bones. They
also demonstrated that testing speed, sampling position and
intracranial variation, all have a significant effect on mechan-
ical performance. Similarly, Evans et al. found tensile strength
of right human parietal bone was 12% higher than left parietal
bone. By testing the compressive strength of right and left
parietal bones, these were found similar in longitudinal direc-
tion while in the transverse direction, the compressive strength
for the left parietal bone was 16% higher than the right side
[49], hence showing variation of properties based on location
and the direction of force applied.
As previously mentioned, the shape of cranial bones is
asymmetrical and complex; therefore, the anatomical location
of the defect dictates specificity in implant design [55].
Moreover, in order to address this variation, craniofacial im-
plants should be designed to follow the contour of the defect
and also have fixation plates in order to be attached to the
surrounding native skull bone. Implants can be uniaxial if
spanning either right or left side of the body or biaxial if
traversing across the body midline. Uniaxial implants are easy
to design as the unaffected side can be used as a template for
designing the graft while biaxial implants are difficult to de-
sign as mirroring is not possible [39, 56]. Hence, in order to
address the biomechanical requirements, the defect type is
another aspect that should be considered during the develop-
ment process.
Regarding cranium defects, they can range from a few cm2
to larger than 100 cm2. Poukens et al. have classified cranial
defects into six categories based on the complexity of design-
ing, size and whether orbital rim is involved [57]. Type I, II
and III defects do not involve the orbital rim, which is instead
involved for the type IV, V, and VI. The defects with area less
than 5 cm2 are classified as type I defects, greater than 5 cm2
but less than 100 cm2 are type II defects, greater than 100 cm2
are type III defects. If the area is less than 5 cm2 with orbital
involvement, these are classified as type IV, whereas defects
with area larger than 100 cm2 are classified as type V defects.
Lastly, type VI defects have area greater than 100 cm2 with
crossing midline of the skull. Based on the different types of
cranial defects, materials with different mechanical perfor-
mance need to be used for the development of craniofacial
implants. For example, cranium implants have to protect the
brain from external impact and stress forces; hence, they re-
quire tough material, whereas for orbital floor implants, which
are not subjected to any external forces and support the eye
ball only structurally, materials with limited toughness are
suitable enough [57].
3 Conventional treatments
For centuries, surgeons have attempted to repair craniofacial
defects with animal tissues. In 1668, Van Meekeren success-
fully documented the first procedure grafting a dog skull bone
into a war wounded soldier’s head without adverse
Table 1 Mechanical properties of
human cortical bone Longitudinal direction Transverse direction References
Tensile strength (MPa) 133–170 43–64 [50, 51]
Compressive strength (MPa) 70–280 133–167 [52–54]
Young’s modulus (GPa) 11–21 5–13 [50, 53, 54]
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immunological response [58], and in 1901, Marchand et al.
reported that also animal horns could be accepted as xeno-
grafts with no negative response [59]. Later on, bones from
other animals such as rabbits, eagles, apes, calves and gooses
were used as xenografts in humans; however, due to ethical
issues these approaches were soon abandoned [60–62]. On the
other hand, good success with autografts provided negligible
justification for further xenograft applications [59].
Autografts have been used historically for craniofacial de-
fect repair due to their positive immune response, osteogenic
cells retention and enhanced healing activity [63–65]. The first
autograft-based craniofacial repair was credited to Mr.
Walther in 1821 [65]. Following this, in 1889, Seydel reported
the first successful reconstruction of human cranium by using
tibia bone tissue pieces. Moreover, bones harvested from ribs,
scapula, ilium, sternum and fascia were also tested for cranial
repair [66]. Although autografts are still considered as the
“gold standard” for craniofacial repair, they are not risk-free
approaches [25, 67–71]. Piitulainen et al. [72] and Matsuno
et al. [73] reported ~ 25% infectious complications following
cranioplasty with autografts. Another complication with auto-
grafts is native bone resorption after the surgery, which is also
dependant on patients age [71, 74, 75]. Bowers et al. reported
that 50% paediatric patients, who underwent autograft-based
surgery, experienced bone resorption in comparison to only
7% of adults [74]. In addition to these complications, another
important aspect that limited the use of autografts over the
years related to the poor customizable properties, for which
shape and size of the injured tissue were rarely matched.
Beyond that, the excision of bone from the donor site engen-
ders an additional injury site, hence leading to longer recovery
and extended operating times [39, 76, 77].
The limitations associated with autografts were addressed
in 1915, when for the first time Morestin reported the use of
cadaver cartilage for craniofacial repair [78]. Cartilage is read-
ily obtainable and easy to shape and its resistance to infection
is an additional advantage for cranial bone repair. Several
successful cases of cartilage-based cranioplasty were reported
by Monroe [79]. However, it was soon realised that cartilage
was not mechanically strong and did not show mineralisation
potential. Therefore, it was then realised that cartilage was not
a suitable material for cranial bone repair [80]. In 1917,
Dambrin and Sicard investigated the potential of cadaveric
skull for cranial reconstruction [81]; the collected bone was
treated with sodium carbonate, alcohol, xylol and ether and
ultimately heat sterilised, before implantation, in order to min-
imise the immune response [81]. However, due to impedi-
ments of bone resorption and the high risk of infection, nev-
ertheless, sterilisation measures used to be applied, craniofa-
cial reconstruction with cadaveric skull had limited applica-
tion [82, 83]. Therefore, the need to find alternative grafts, for
which different shapes and sizes could be available readily
and which did not initiate adverse immune response upon
grafting was measured of paramount importance. In light of
the above-mentioned limitations and in an effort to overcome
the life-threatening challenges in craniofacial surgery, the
adoption of alternative strategies revealed highly necessary.
4 Biomaterials for craniofacial implants
The bone has low thermal conductivity to protect damage to
underlying brain tissue from heat transfer from the atmosphere;
therefore, the implant material should be analogous to bone.
Magnetism of the implant can interfere with the security screen-
ing, just as radiolucency interferes with the post-operative im-
aging assessment [66, 84]. In addition to addressing the limita-
tions of natural grafts, an ideal biomaterial for craniofacial im-
plants should be biocompatible, have low heat conduction and
are non-magnetic, radiolucent, durable, easy to process and
cost-effective. Several biomaterials have been investigated dur-
ing the years for craniofacial reconstruction in order to over-
come the challenges associated with the use of autografts and
allografts; these include metals, ceramics and polymers as well
as a combination of them [66]. In this section, the different
types of biomaterials currently available, along with their ben-
efits and limitations towards the manufacturing of craniofacial
implants, are reviewed and discussed.
Metals such as aluminium, gold, silver, titanium and their
alloys, are among the oldest biomaterials used to repair cra-
niofacial defects. Although, many have been abandoned dur-
ing the years, because of associated medical complications;
for example, aluminium caused infections and induced epilep-
sy in patients who had cranioplasty with this material [85]. In
comparison, gold has low complication rates; however, it is
very expensive, whereas silver is considered unfavourable due
to its poor mechanical properties and high oxidation affinity
and thus corrosion behaviour [86]. Surgical titanium grade 5
(Ti-6Al-5V), usually referred as titanium, is the most biocom-
patible metal and is widely used in cranium fixation devices
(such as screws, plates), solid plates and meshes [87]. Though
clinical applications of titanium date back to 1966 [88], its
widespread use was only found after 1983 when Branemark
demonstrated the superior biocompatibility and mechanical
properties of this metal [89]. Additionally, titanium and its
alloys have high corrosion resistance, good machinability
and better mechanical properties in comparison to other
metals, thus making them the elected materials in human bone
replacement surgery [90]. However, the higher elastic modu-
lus of titanium alloys (~ 110 GPa) with respect to human
cortical bone (10–30GPa) often is the cause of stress shielding
effects at the bone–implant interface. Stress shielding occurs
when metal implants, such as bone plates and screws, are used
to repair fractures or in joint replacement surgery; the higher
stiffness of the implant results in bone loss as a consequence
of decreased physiologic loading of the bone [15, 91–93]. The
Int J Adv Manuf Technol
stress shielding effect can be minimised by lowering the elas-
tic modulus and increasing the porosity of the implant [94,
95]. For instance, Oh et al. prepared porous titanium implants,
with porosity values around 30%, via powder metallurgy and
Young’s modulus of these decreased to 25 GPa, thus resulting
in the human cortical bone range [95]. However, the release of
aluminium and vanadium ions from grade 5 Ti alloy in the
blood stream limited its use for long-term implantation [96,
97]. Titanium itself is non-toxic both in its ionic and in its
particle form, and Ti ions are subjected to renal excretion
[98]. However, corrosion product of titanium, called rutile,
accumulates in the lymph nodes, liver, spleen, bone marrow
and brain, thus leading to systemic toxicity [99]. Few studies
have also reported the infectious complications associated
with titanium implants, which led to the surgical removal of
the implant itself. Bhatt et al. had to remove 32 craniofacial
mini-plates out of 308 implanted in 153 patients due to infec-
tious complications within 4 years of implantation [100].
Murthy et al. had to replace 6 titanium plates out of 163 due
to infections from 76 patients over a 10-year period [101]. In
addition to infections, which for titanium implants account ~
7–10% of the overall complications [102, 103], radiopacity is
another drawback associated with the use of metal implants.
Particularly, this often leads to artefacts during CT and MRI
scanning and hence makes it difficult for follow-up medical
imaging. Another limitation with metallic biomaterials is their
poor biomimetic behaviour, which prevent cell–material com-
munications, and thus the final integration of the implant
[104]. In order to overcome this issue, surface treatments as
coating or functionalisation have been adopted [104–106]. For
instance, Palmquist et al. found stronger bone anchorage for
laser-modified titanium alloy implants than the machined im-
plants [105, 106]. Metal implants offer a biocompatible and
mechanically strong alternative to biologically derived treat-
ment for replacing bone (Table 2), but considering their com-
plications and limitations, the possibility to explore alternative
biomaterials has been also examined.
Ceramics such as bioactive glasses (BAGs) and calcium
phosphates have been then considered for craniofacial bone tis-
sue repair [107]. The first BAG was synthetically manufactured
in 1971 by Hench and afterward commercially known as
Bioglass 45S5 [108, 109]. The main components of BAGs,
Na2O, CaO, SiO2 and P2O5 support osteoblast cells. BAGs also
bond with the host bone soft tissue without formation of fibrous
tissue [110]. Their bioactivity, as assessed by Peltola et al. in a
skull bone defect, revealed new bone formation evident from 4
weeks of implantation [111]. Although the elastic modulus of
BAGs (~ 30 GPa) resembles the one of human bone, their
amorphous structure makes them brittle and thus inappropriate
for load-bearing applications [112]. Another shortcoming with
BAGs is their limited processability; they cannot be reshaped
during the surgery to improve the fit of the implant if required
[112, 113]. Another class of ceramics, calcium phosphates are
highly biocompatible and have chemical compositions and
structures that are very similar to the mineral phase of human
bone [114]. Such materials can be resorbed through a cell-
mediated procedure involving osteoclast activity; for instance,
the HA coating on implants is resorbed by the osteoclast activity
during bone remodelling [115–117]. Tricalcium phosphates
(TCP), e.g. beta-tricalcium phosphate (β-TCP), are a type of
calcium phosphate with Ca/P very close to the natural bone
tissue. Hence, they provide calcium and phosphorus in readily
available form for development of new bone. Both HA and TCP
are biocompatible and biodegradable, with HA degradation rate
more suitable for orthopaedic applications allowing time for
deposition of new bone [118]. Morphometric analysis by
Eggli et al. revealed that up to 85% of TCP was degraded after
6 months of implantation in rabbits, whereas only 5.4% volume
reduction observed with implanted HA in the same period, in-
dicating a bettermatchwith the regeneration of new tissue [119].
Bioceramics are advantageous over metals as being more bio-
compatible and bioactive, although their mechanical properties
are lower compared to the native bone, hence limiting their use
as load-bearing implant materials and giving more promise as
coating and/or reinforcing phase [120, 121]. In 2013, Brie et al.
implanted HA craniofacial implants into 8 patients prepared via
stereolithography and sintering. Since the implants were de-
signed for individual patients the cosmetic results were satisfac-
tory and no fractures or infections were observed to up to the 12-
month follow-up [19].
Due to an array of limitations observed with metallic and
ceramic biomaterials, the use of polymers has been considered
as alternative class for craniofacial repair, particularly due to
their radiolucency, high strength to weight ratio, good process-
ability and low cost in comparison to metals and ceramics
[122]. Moreover, polymers avoid possible artefacts in imaging
scanning like CT or MRI due to their radiolucency and being
nonmagnetic, thus facilitating unobstructed post-operative clin-
ical diagnoses. Among the others, PMMA, PEEK and PE are
the polymers most widely used in craniofacial surgery. Porous
PE is soft and frequently applied for the augmentation of facial
bone [123, 124]. PMMA was the first synthetic material used
for a biomedical application and is now broadly used as pros-
thetic fixation devices or orthopaedic devices due to its low
toxicity and good handle ability during surgery [125, 126].
However, despite the good qualities, PMMA implants show
poor adhesion with the surrounding soft tissues [127].
Additionally, a large amount of heat is released during its po-
lymerisation in vivo, causing the temperature rise up to 100 °C
which may cause damage to the surrounding soft tissues [128].
PEEK is a biocompatible and semi-crystalline thermoplastic
polymer, possessing high heat and gamma ray tolerance, which
allow for different sterilisation methods [56]. Strength, stiffness
and radiolucency of PEEK are comparable to those of cortical
bone [129]; however, due to its bioinert and hydrophobic na-
ture, its binding ability with the surrounding tissues after
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implantation is very low [130, 131]. Bioinertness is the com-
mon shortcoming that can be extended to the whole class of
synthetic polymers and which encouraged researchers to move
their focus into a new direction. The physico-chemical and
mechanical properties of various biomaterials, for each of the
three classes described above, have been summarised in
Table 2. This provides a reference for their selection towards
the development of an implant according to the requirements of
the host tissue that needs to be replaced or repaired.
5 Polymeric matrix composite materials
Composite materials are the result of the combination of two
or more phases, where the reinforcement element and the ma-
trix are integrated to improve the properties of the final mate-
rial [143]. Composite materials’ properties depend upon the
composition and the interaction between the individual phases
[144]. Human bone is a clear example of natural composite
material, based on mineral HA crystals embedded into an
organic collagen phase [145]. In the context of craniofacial
repair, recent literature has highlighted the use of composites
to tailor the mechanical properties and enhance the bioactivity
of the implant [22, 25, 113, 146].
Composites of PMMA have been investigated to address
the issues of large amount of heat released during the poly-
mer i sa t ion reac t ion of polymer and i t s l imi ted
osseointegration. For instance, composites of ceramics in
PMMA have shown improved bioactivity, increased cell ad-
hesion in vitro and reduction in the amount of heat released
during the polymerisation as compared to PMMA alone.
Moreover, PMMA composites with BAG, silicates, HA and
TCP enhance the mechanical properties of PMMA in addition
to its bioactivity [147–156]. HA and TCP incorporation
significantly reduces the amount of heat generated during
the polymerisation of PMMA and improve cell attachment
[157–159]. For instance, Chu et al. and Fang et al. reported
that the incorporation of HA, TCP and chitosan in PMMA
significantly reduced the amount of heat released during po-
lymerization [146, 160]. Furthermore, Fang et al. also ob-
served improved in vitro and in vivo osseointegration of
PMMA composites with TCP and chitosan [160].
PMMA/BAG composites have shown good bioactivity as
well as enhanced mechanical strength [148, 161, 162]. For
instance, composite of PMMA and silicate-based bioceramic
showed good cell attachment, proper setting time and high
mechanical strength as compared to PMMA alone [161].
Hamizah et al. prepared PMMA composites with HA and
glass–ceramic that showed apatite layer formation in simulat-
ed body fluid (SBF), improved flexural strength and enhanced
thermal properties [24]. Moreover, in vivo study by Haach
et al. showed improved bioactivity of PMMAcomposites with
HA and BAG; however, compressive strength decreased, al-
though still within an acceptable range for this to be consid-
ered a bone substitute [25]. Ku et al. prepared PMMA com-
posite with surface-modified HA, in order to enhance
ceramic–polymer phase interaction. HA nanoparticles were
modified with either ethylene glycol or ɛ-caprolactone before
blending with PMMA; this enhanced the compressive
strength of the composite along with improved bioactive sur-
face [162]. Furthermore, PMMA/BAG custom-made cranio-
facial implants were clinically applied to repair calvarial and
facial defects; 5-year follow-up found patients’ clinical recov-
ery with good aesthetic and functional outcome [113].
Composites of PEEK are becoming popular to enhance its
bioactivity and to tailor the final mechanical properties, par-
ticularly for load-bearing orthopaedic applications [163].
Carbon-fibre reinforced PEEK (CFR-PEEK) material has
Table 2 Summary of different biomaterials for implantation with their material properties
Biomaterial Density
(gr/cm3)
Biological
response
Degradable Elastic modulus
(GPa)
Ultimate tensile
strength (MPa)
Yield strength
(MPa)
Bending
strength (MPa)
References
Co–Cr alloys 9.1 Biotolerant No 9.1 1147 629 [132, 133]
Stainless steel 7.95 Biotolerant No 193 670 366 [132, 134]
Titanium alloy Bioinert No 110 960–970 850–900 [135]
Calcium phosphates Bioactive Yes 1.66–2.34 6–10 [134, 136, 137]
Bioactive glasses 2.7 Bioactive Yes 35 42 [134, 138]
PEEK 1.3 Biotolerant No 4 93 170 [133, 139, 140]
PMMA 1.12 Biotolerant No 1.5–4.1 24–49 134 [133]
PLA Biotolerant Yes 1.6 70 [141]
PCL 1.15 Biotolerant Yes 0.3 17 [141, 142]
Biotolerant, the products released due to corrosion and wear of implant material may lead to toxic or allergic reactions and show fibrous connective tissue
attachment; bioinert, the products released due to corrosion and wear of implant are non-toxic and show fibrous connective tissue attachment; bioactive,
the products released and the surface of implant encourage cell attachment, differentiation and proliferation; develop a chemical bond of a cohesive
nature with bone
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been the first FDA-approved composite of PEEK used for
biomedical applications. Elastic modulus and tensile strength
of the composite increased with the increase of the percentage
of carbon fibres [164–166]. Specifically, they increased from
3.79 GPa and 95.21 MPa to 7.37 GPa and 101.41 MPa re-
spectively, by simply adding 5% w/w/CFR into PEEK matrix
[40]. In another study, the addition of 40 wt%HA reduced the
mechanical properties of PEEK due to the agglomeration and
poor dispersion of ceramic particles in the polymeric matrix;
for example, the ultimate tensile strength of PEEK decreased
to 45MPa (i.e. reduction of 45% from 85MPa, although were
still within the range of mechanical strength of human cortical
bone [167]). Kim et al. incorporated HA-coated calcium sili-
cate spheres into PEEK to increase its bioactivity and mimic
natural bone. They observed increased bioactivity with
in vitro apatite formation as well as mechanical properties
analogous to native bone [168]. Biomechanical properties of
PEEK reinforced with strontium substituted hydroxyapatite
(Sr-HA/PEEK) have been also investigated. The results evi-
denced an increased in vitro mineralisation and bending mod-
ulus by using 25–30% w/w of Sr-HA in PEEK [169]. Nano-
silica (nSiO2) and nano-alumina (nAl2O3) have been incorpo-
rated into PEEK in amount ranging between the 20 and 50%
w/w. The result was an improved mechanical performance
both in terms of elastic modulus and tensile strength [170].
Wu et al. prepared composite of PEEK with nano-titania (n-
TiO2) and observed better biological properties of the com-
posite with respect to the bare materials, i.e. enhanced cell
attachment and increased osteoblast cell spreading [171].
The use of bioactive reinforced polymers is still widely inves-
tigated. In a very recent study,Ma et al. found that the addition
of nano-hydroxyapatite improved the apatite formation ability
of PEEK composites as well as increased the elastic modulus
and bending strength in comparison to PEEK alone [172].
However, the manufacturing process Ma et al. adopted for
the processing of the composite materials is still far from being
patient specific.
6 Rationale for the use of additive
manufacturing for craniofacial implants
Conventional technologies such as injection moulding, extru-
sion, forging and compaction have played a key role in
manufacturing biomedical implants. Conventional methods
of manufacturing can produce standardised parts cheaply
and quickly in large quantities, although they cannot produce
custom-made parts. AM instead allows the manufacture of
complex 3D parts that can also be modified according to pa-
tient individual needs. Conventional technologies also strug-
gle to produce parts which are complex and have a high de-
gree of dimensional accuracy, with the need for a dedicated
tool meaning that the cost of producing a part for a specific
patient is prohibitive [173].
Since its introduction, AM technology makes it possible to
produce customisable 3D objects with intricate shapes and great
accuracy.Within the biomedical field, AM has allowed the man-
ufacture of patient-specific implants (PSIs) bypassing the re-
quirements of additional tooling and manufacturing cost [174,
175]. In essence, complex shapes are designed by CAD software
or derived from CT data, custom-designed and produced with
high precision and specific to the needs of the patient, as shown
in Fig. 1. One example of this technique in practice is for bone
implants. The bone is scanned by CT or MRI and used to gen-
erate a 2D Digital Imaging Communication and Medicine
(DICOM) of the defected part. This is then converted using 3D
design tools (e.g. CAD) into a 3D native format (e.g. Standard
Tessellation Language (STL) for further processing [176–178].
STL is a widely accepted software standard and is compatible
with CAD software for the manipulation and design of parts for
3D printers. A basic example of this working in practice is a bone
being scanned using CT. The information is exported into the
DICOM format and the soft tissue data filtered leaving only the
bone data. This can then be used to design an implant which
corrects the defect. This design is then converted to a 3D pro-
cessing software package that is used to 3D print the exact struc-
ture required for that patient [176].
AM spans a variety of techniques, including extrusion-
based printing, laser sintering and photo-polymerisation. In
extrusion-based printing, the polymer in the form of filament
is fed into the printing head which melts the polymer and
extrudes it and the molten polymer is deposited layer after
layer horizontally; an example is fused deposition modelling
(FDM). In laser sintering, the feedstock is a powder which is
deposited in a thin layer. A laser beam melts the powder par-
ticles, and another thin layer of powder is deposited on top and
the process is repeated, layer upon layer, in order to build 3D
structure. Examples of laser sintering include selective laser
sintering (SLS), selective laser melting (SLM) and electron
beammelting (EBM). Another form of AM is photo-polymer-
isation, in which the photo-sensitive liquid resin is cured and
hardened by using light to produce a three-dimensional struc-
ture. Examples of this technique are stereolithography (SLA)
and digital light processing (DLP).
Another benefit of AM for manufacture of implants is its
versatility that allows the user to control the deposition of
material in a three-dimensional space, which enables manu-
facture of complex shapes with pre-defined porosity. Implants
can be designed with well-defined pores or channels. For ex-
ample, mesh-like structures are produced for cranioplasty of
skull defects which have predesigned holes or hinges for
screwing to the skull [179]. The ongoing research in process-
ing new biomaterials via 3D printing technologies and for
craniofacial implants is described in the latter sections.
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7 3D printed composite materials
for craniofacial implants
In comparison to the production of monophasic parts, AM of
composites requires optimisation of printing parameters in
order to obtain the required porosity and mechanical strength.
In relation to FDM, creating a composite-based filament is
complicated, as not only must the diameter of the filament
be consistent but also the raw components need to be well
dispersed in order to avoid agglomeration that can affect the
final print. This is further complicated by the differences in
physico-chemical properties between polymer and ceramic
phase [142, 180, 181]. For SLS, a fine powder is required with
all the powder particles being in a specific size range in order
to achieve evenly sized layers. Generally, the finer the pow-
der, the better the surface finish. Prior to SLS printing, pre-
processing of materials is necessary for optimal outcome.
Researchers have also used techniques such as spray drying
and freeze drying (for low-temperature polymers) to remove
moisture. Due to the large surface area, atmospheric moisture
can be absorbed onto the powder and this can impact the
printing quality and the mechanical properties of the final
printed parts [182, 183]. Following an extensive review of
the current literature, only a few research studies have been
found, predominantly based on the use of FDM and SLS as
elected procedures for printing composites, and whose find-
ings are summarised in Table 3. The mechanical properties of
same formulation composites vary with the fabrication meth-
od used as seen in composites of CFR/PEEK [184, 185].
Hao et al. have optimised SLS printing parameters of HA
reinforced PE composites, which also showed improved bio-
activity of composite implants in vitro as HA particle are ex-
posed on surface of the printed scaffold [186]. Subsequent
tests for the biological behaviour include techniques to assess
growth of cells and their differentiation, metabolism and the
deposition of new bone [183, 186, 187]. Xia et al. assessed the
new bone growth via CT scan at 3, 6 and 9 weeks after im-
plantation of 3D printed bioactive scaffolds, based on the
combination of PCL and HA, into rabbit femur (Fig. 2). The
histology shows higher amount of new bone in defects im-
planted with PCL composite with 15% HA in comparison to
PCL alone, thus demonstrating the actual benefits of low
amount of ceramic phase in bone regeneration [183].
Composites of HA with PLGA (poly(lactic-co-glycolic acid))
prepared by Huang et al. showed higher new bone deposition
than autologous grafts [188]. Similar bioactivity assessments
provided by other research groups show benefits of HA addi-
tion to composites for advancement of bioactivity by en-
hanced cell attachment, metabolism and mineral deposition
as compared to pure polymers [21, 189]. The sintered mate-
rials have a porous structure with interconnected pores which
is useful for ingrowth of bone and soft tissue. HA combined
with PVA (polyvinyl acetate) can be processed via SLS to
print scaffolds with enhanced bioactivity in comparison to
PVA alone [182]. The possibility of 3D printing composites
with tailorable bioactivity and mechanical properties proves
their suitability as a manufacturing technique for craniofacial
implants.
The 3D printing of composites is a promising step towards
creation of craniofacial composite-based implants. However,
their in vivo behaviour should be assessed prior to the clinical
trials. The latest research into composites has successfully
shown the promising in vivo behaviour of composites al-
though not manufactured using AM but with conventional
techniques, as listed in Table 4. For instance, Yu et al. and
Ma et al. tested the moulded composites of PEEK and HA
Fig. 1 Design and manufacturing
procedure for an implant: direct
and indirect routes
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with 10, 20, 30 and 40% ceramic content in vitro. The apatite
formation ability of composites was higher than PEEK alone
after immersion in simulated body fluid [167]. Additionally,
they evaluated the cell attachment, proliferation, spreading
in vitro and osseointegration in a rabbit cranial defect model,
all of which showed improvement with additional ceramic
content [167]. In an attempt to improve the bioactivity of
PEEK, Lee et al. cold sprayed HA onto PEEK and observed
early cell adhesion and increase in viability of hBMSCs [194].
Another group added metal-doped HA to improve bioactivity
of compression moulded PEEK; strontium containing com-
posites outperformed HA/PEEK composites for in vitro
mineralisation [169]. An alternative to isotropic composites,
functionally graded composites were prepared in a 2-step pro-
cess which advance the cell adhesion. Initially, composites
were prepared by addition of HA during PEEK synthesis
which gives excellent dispersion of HA in PEEK matrix.
Three layers of different HA vol% were stacked in a steel
die before hot pressing to create functionally graded PEEK/
HA composites [195]. It can be concluded that even with
different ways of manufacturing of composite scaffolds, the
in vitro and in vivo results show increment in bioactivity with
HA inclusion. Further research should be directed towards
additively manufacturing of these composites as this should
impart the physiological benefits of materials for implantation
and will be vital in developing better fitting PSIs ensuring
enhancement from off the shelf implants.
8 Commercial craniofacial implants
The use of AM inmedicine is increasing at a rapid rate and the
worldwide market of 3D printing healthcare market size is
expected to reach $3.7 billion by 2026 [202]. Commercial
providers have resorted to different types of AM technologies
in order to provide custom craniofacial implants from patient
medical imaging data. A list of commercially available
craniofacial implants and the related provider is reported in
Table 5. Currently available FDA-approved craniofacial im-
plants are made from titanium, PEEK or PMMA and most
centres use either off the shelf implants for craniofacial im-
plantation or the custom-made implants from commercial
companies. For instance, Stryker uses SLS for production of
custom PEEK implants while OXPEKK used SLS for PEKK
(polyetherketone ketone). The implants manufactured via AM
are designed with prepatterned holes and also lattices which
allows for space for soft tissue ingrowth and anchorage and
also reduces the weight of the implant. Custom implants have
improved fit and reduced operative times in comparison to the
off the shelf implants which had to be adjusted in the operating
theatre.
Although, the post-operative results of fit with these cus-
tom implants are very promising but there is limited integra-
tion with the native bone. Implant–bone integration is vital
since transfer of load from implant to the bone keeps it
healthy, or else there is progressive weakening of the adjacent
bone which may cause implant exposure, infection and ulti-
mately removal [203, 204]. To overcome this barrier, re-
searchers are focussing on use of composites for improving
implant–bone integration by increasing the bioactivity of im-
plant materials.
The first step towards a composite craniofacial implant was
taken by Swedish company OSSDSIGN, who have developed
a composite of Ti mesh overlaid with calcium phosphate com-
position. The company claims the stability and fixation of
implant is provided by the Ti mesh while the ceramic part
helps in healing since calcium phosphates can be remodelled
by osteoclasts. A retrospective clinical study has shown a
reduced infection rate (2%) in a 25-month follow-up and tis-
sue samples demonstrate in situ bone regeneration and
osseointegration [196]. Another supplier of FDA-approved
PEEK, Invibio Biomaterial Solutions supply PEEK-
OPTIMA® for craniofacial implants which are processed
via CAD/CAM for PSIs. They also provide PEEK-
Fig. 2 Composite scaffold produced by SLS. (a) Sintered PCL/nano-HA
3D porous structure. (b) Implantation of the scaffold into the defect. (c)
Micro-CT reconstructions after 3, 6 and 9 weeks of a cavitary defect
production. Histological evaluation of new bone formation promoted by
(D-1 and D-2) pure PCL and (D-3 and D-4) 15% nano-HA/PCL 3D
printed scaffolds at 9 weeks of implantation at 20× (D-1 and D-3) and
100× (D-2 andD-3) magnification. Reprintedwith permission from [183]
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OPTIMA® HA, which is a composite with HA that shows
improved bone–implant interface and reduction in fibrous tis-
sue surrounding the implant [201].
9 Conclusions and future perspective
AM is highly versatile and increasingly being used for pro-
duction of custom craniofacial implants of metals and poly-
mers, although they are the two classes of biomaterials mainly
used, as they provide appropriate structural replacement of the
damaged/diseased craniofacial bone tissue, they still suffer
from several limitations. Specifically, they are both classified
as bioinert, and in the case ofmetallic implants, they often lead
to stress shielding phenomena with the host tissue. In this
work, the current state of the art towards the development of
composite-based implants and also their processing via AM
have been reviewed. The main focus was dedicated to poly-
meric based composites reinforced with a ceramic phase.
According to the findings reported in the recent literature,
through the use of composites, and by adjusting the compo-
nent ratios of the main phases, it is possible to achieve an
Table 5 Commercial implants used in craniofacial surgery including PSIs
Establishment Product details Images
BioArchitects EBM Ti custom craniofacial implants
Ortho Baltic DMLS Ti custom craniofacial 
implants
Oxford Performance 
Materials
OsteoFab- OXPEKK™
SLS PEKK custom craniofacial 
prostheses
DePuy Synthes TRUMATCH MatrixMANDIBLE™
Off the shelf fixation products
Stryker PEEK Customized cranial implant-
SLS PEEK
Stryker MEDPOR
® 
Customized cranial 
implant - Porous PE 
Stryker PMMA Customized cranial implant 
OssDsign AB OssDsign
® 
- Cranial PSI- Ti and 
bioceramic composite
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adequate balance in terms of physico-chemical, mechanical
and biological properties.
Currently available in vivo studies, by using animal
models have shown that the inclusion of HA in polymer-
ic composites, especially PEEK, attains a material with
adequate strength and most importantly with bioactive
properties. Thus, PEEK/HA composites can be consid-
ered promising candidates for the development of cranio-
facial implants.
Regarding the opportunity to produce customised implants
in the clinical setting, the major barriers towards the adoption
of AM are no longer technological but rather relate to under-
standing the clinical effectiveness. Long-term follow-up stud-
ies on differences in success rates between different
composite-based materials additively manufactured are need-
ed toward their potential clinical application as implants. More
work must be done to understand the tolerances and require-
ments of AM implants in a clinical setting as well as under-
standing the long-term implications of implanted AM parts
in vivo. Also, materials’ developers should direct efforts not
only to achieve adequate biological and mechanical properties
but also their easy processability via AM. From a technolog-
ical development point of view, the prospects of manufactur-
ing composites for PSIs is encouraging and further research
should be addressed towards in vivo tests, clinical trials and
regulatory approvals to incorporate into standard clinical prac-
tice. According to the United Nations, the population above
60 years is rising and would double by 2050. This will in turn
increase the demands for custom implants. In the future, the
high demand of customised implants may require implant
manufacturing unit in every orthopaedic hospital to produce
implant on-site rather than outsourcing and AM would be the
manufacturing technology of choice for implants serving the
patient’s needs and demands. As this demand for patient-
specific implants increases, the need to democratise the design
and manufacture of them will become more pressing. Point of
care manufacturing is already becoming a reality in several
leading hospitals worldwide. These highly integrated care fa-
cilities are demonstrating the impact of bringing together ma-
terial scientists, clinicians, biomedical engineers and computer
scientists to produce truly personalised care for patients.
Personalised design of implants ensures the best outcomes
for the patient over the lifetime of the implant. Lowering over-
all costs of such interventions allows the broader adoption of
this approach, maximising the impact.
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